Jennifer Mailn discusses the cost structure of novel therapeutics
Randy Vogenberg discusses the challenge of covering cancer care as survivorship increases
John Hennessy discusses the challenges in determining the cost value of cancer treatments
Dr. Mullins speaks about the Academy of Managed Care Pharmacy (AMCP) and the importance of their input regarding the value of healthcare in oncology. This organization is in a good position to inform policymakers about the cost-effectiveness of various cancer therapies.
Matthew Palmgren discusses the benefits of personalized medicines
John Hennessy discusses the "affordabilty index" of curing cancer
Gary Owens discusses the complexities of cost-sharing as it relates to cancer care. He cites the fact that the cost of cancer care has increased dramatically and benefit designs have decreased, disproportionately affecting cancer patients. He also talks about AVBCC's role in moving the discussion toward solving the issues surrounding the cost of cancer treatment.
Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products
Jennifer Malin describes some of the key issues in creating affordable cancer care
Andrew Stainthorpe, PhD, PASLU, NICE, talks about why the FDA should not take drug cost into account when weighing the approval of expensive medications.
Page 1 of 2
Results 1 - 10 of 12
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME